Keywords: biogen, merck, sign, million, deal, drug, companies

Biogen & Merck Sign $130 Million Deal

Article | 04 December 1997

Print This

US drug companies Biogen and Merck & Co have signed a collaborativeagreement for the development of an aerosolized anti-VLA-4 small molecule ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in